AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2016
Feb 17, 2016
30016_dirs_2016-02-17_377d7302-6fea-48b6-8952-2df953d8ef63.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2016-02-14
Reporting Person: Williams Michael J PhD (Director, Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-02-14 | Common Stock | M | 514 | $0.00 | Acquired | 40856 | Direct |
| 2016-02-14 | Common Stock | M | 514 | $0.00 | Acquired | 41370 | Direct |
| 2016-02-14 | Common Stock | M | 545 | $0.00 | Acquired | 41915 | Direct |
| 2016-02-14 | Common Stock | M | 403 | $0.00 | Acquired | 42318 | Direct |
| 2016-02-14 | Common Stock | M | 472 | $0.00 | Acquired | 42790 | Direct |
| 2016-02-14 | Common Stock | F | 779 | $67.85 | Disposed | 42011 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-02-14 | Non-Qualified Stock Option (right-to-buy) | $67.85 | A | 13424 | Acquired | 2026-02-13 | Common Stock (13424) | Direct |
| 2016-02-14 | Incentive Stock Option (right-to-buy) | $67.85 | A | 1476 | Acquired | 2026-02-13 | Common Stock (1476) | Direct |
| 2016-02-14 | Restricted Stock Unit | $ | A | 3685 | Acquired | 2026-02-13 | Common Stock (3685) | Direct |
| 2016-02-14 | Restricted Stock Unit | $ | M | 514 | Disposed | Common Stock (514) | Direct | |
| 2016-02-14 | Restricted Stock Unit | $ | M | 514 | Disposed | Common Stock (514) | Direct | |
| 2016-02-14 | Restricted Stock Unit | $ | M | 545 | Disposed | Common Stock (545) | Direct | |
| 2016-02-14 | Restricted Stock Unit | $ | M | 403 | Disposed | Common Stock (403) | Direct | |
| 2016-02-14 | Restricted Stock Unit | $ | M | 472 | Disposed | Common Stock (472) | Direct |
Footnotes
F1: Includes 84 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on December 31, 2015.
F2: Closing price of Issuer's common stock on the NASDAQ market on February 12, 2016.
F3: Grant of option to buy shares of Issuer common stock that becomes exercisable in five annual installments beginning February 14, 2017.
F4: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2017.
F5: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five equal annual installments, beginning February 14, 2012 and has been adjusted to reflect the the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015 (the "Stock Split").
F6: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2013 and has been adjusted to reflect the Stock Split.
F7: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2014 and has been adjusted to reflect the Stock Split.
F8: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2015 and has been adjusted to reflect the Stock Split.
F9: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2016 and has been adjusted to reflect the Stock Split.
F10: Not applicable.